EPISODE · May 30, 2013 · 7 MIN
The SUCCEED Trial: Maintenance Ridaforolimus for Metastatic Soft- Tissue Sarcomas
from Journal of Clinical Oncology (JCO) Podcast
This podcast provides observations and commentary on the JCO article,"Results of an international randomized phase 3 trial of the mTOR inhibitor, ridaforolimus, versus placebo to control metastatic sarcomas in patients following benefit from prior chemotherapy" by authors George Demetri, et al.
Embed this episode
NOW PLAYING
The SUCCEED Trial: Maintenance Ridaforolimus for Metastatic Soft- Tissue Sarcomas
0:00
7:18
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Journal of Clinical Oncology (JCO) Podcast?
This episode is 7 minutes long.
When was this Journal of Clinical Oncology (JCO) Podcast episode published?
This episode was published on May 30, 2013.
Can I download this Journal of Clinical Oncology (JCO) Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!